|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2008-1-18
|
|
pubmed:abstractText |
Fluid therapy induces haemodilution related to plasma volume expansion. The aim of our study was to compare haemodilution after a single hydroxyethyl starches (HES) 130/0.4 infusion in two groups of patients, one with and one without sepsis. We hypothesized that a single HES challenge would induce similar sustained haemodilution in both groups.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
1399-6576
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
52
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
229-35
|
|
pubmed:meshHeading |
pubmed-meshheading:18034867-Aged,
pubmed-meshheading:18034867-Blood Pressure,
pubmed-meshheading:18034867-Blood Proteins,
pubmed-meshheading:18034867-Blood Viscosity,
pubmed-meshheading:18034867-Critical Illness,
pubmed-meshheading:18034867-Heart Rate,
pubmed-meshheading:18034867-Hematocrit,
pubmed-meshheading:18034867-Hemodilution,
pubmed-meshheading:18034867-Hetastarch,
pubmed-meshheading:18034867-Humans,
pubmed-meshheading:18034867-Hypovolemia,
pubmed-meshheading:18034867-Middle Aged,
pubmed-meshheading:18034867-Plasma Substitutes,
pubmed-meshheading:18034867-Prospective Studies,
pubmed-meshheading:18034867-Sepsis,
pubmed-meshheading:18034867-Serum Albumin,
pubmed-meshheading:18034867-Time Factors,
pubmed-meshheading:18034867-Treatment Outcome
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
Haemodilution induced by hydroxyethyl starches 130/0.4 is similar in septic and non-septic patients.
|
|
pubmed:affiliation |
AP-HP, Saint-Antoine Teaching Hospital, Medical Intensive Care Unit, Paris, F-75012 France. pascal.meyer@ch-sud-francilien.fr
|
|
pubmed:publicationType |
Journal Article,
Controlled Clinical Trial
|
